首页 | 本学科首页   官方微博 | 高级检索  
     

检测端粒酶活性在肺癌早期诊断中的价值
引用本文:Gu T,Wang X,Wang X,Wang W,Liu Y,Zhang B,Shi Y,Zhang Z,Sun Q,Xue T,Zhang X,Liu Z,Zhu S,Mao X. 检测端粒酶活性在肺癌早期诊断中的价值[J]. 中国肺癌杂志, 2001, 4(1): 37-40
作者姓名:Gu T  Wang X  Wang X  Wang W  Liu Y  Zhang B  Shi Y  Zhang Z  Sun Q  Xue T  Zhang X  Liu Z  Zhu S  Mao X
作者单位:1. 徐州医学院肿瘤学教研室
2. 徐州医学院附属医院中心实验室
3. 徐州医学院生化与分子生物学中心
4. 徐州医学院附属医院心胸外科
5. 徐州医学院附属医院病理科
6. 徐州医学院附属医院呼吸内科
基金项目:江苏省自然科学基金!(BJ981 1 0 ),江苏省卫生厅重点课题基金!(980 8H)
摘    要:目的 探讨端粒酶作为肺癌肿瘤标记物的可能性 ,评价端粒酶活性对肺癌的早期诊断价值。方法 采用改良银染 -端粒重复序列扩增法 (TRAP)检测 40例原发性支气管肺癌手术标本及 40例CT扫描疑诊为肺癌患者的纤维支气管镜活检标本的端粒酶活性。结果 两组中小细胞肺癌端粒酶阳性率均为 10 0 % ,非小细胞肺癌分别为 84.8%、95 .7%。 40例手术切除肺癌组织的端粒酶阳性率为 87.5 % ( 3 5 /40 ) ,癌旁肺组织为7.5 % ( 3 /40 ) ,正常肺组织无表达 ( 0 /40 ) ,三组间比较有显著性差异 (P <0 .0 1)。 40例CT扫描疑诊为肺癌患者的纤维支气管镜肺活检标本的端粒酶阳性率为 82 .5 % ,肺癌检出的敏感度为 96.4% ,特异度为 71.4% ,准确性为 91.4% ;尤登指数 (Youden’sIndex)J =0 .678,SE(J) =0 .174。结论 端粒酶是灵敏的肺癌肿瘤标记物 ,对纤维支气管镜活检标本行端粒酶活性检测有助于肺癌的早期诊断。

关 键 词:肺肿瘤 端粒酶 早期诊断
修稿时间:2000-07-13

The value of detecting telomerase activity on early diagnosis of lung cancer
Gu T,Wang X,Wang X,Wang W,Liu Y,Zhang B,Shi Y,Zhang Z,Sun Q,Xue T,Zhang X,Liu Z,Zhu S,Mao X. The value of detecting telomerase activity on early diagnosis of lung cancer[J]. Chinese journal of lung cancer, 2001, 4(1): 37-40
Authors:Gu T  Wang X  Wang X  Wang W  Liu Y  Zhang B  Shi Y  Zhang Z  Sun Q  Xue T  Zhang X  Liu Z  Zhu S  Mao X
Affiliation:GU Tao,WANG Xu,WANG Xiuying,WANG Wei,LIU Yong,ZHANG Bei,SHI Yanxia,ZHANG Zhongming,SUN Quansheng,XUE Tao,ZHANG Xiaoxuan,LIU Zhifa,ZHU Shuyang,MAO Xiaofen. Department of Oncology,Xuzhou Medical College,Xuzhou,Jiangsu 221002,P.R.China
Abstract:Objective To explore the possibility of telomerase as tumor marker of lung cancer and to evaluate its value on early diagnosis of lung cancer. Methods Telomerase activity was measured in 40 resected specimens of lung cancer and 40 preoperative fibro-optic bronchoscope biopsied specimens of suspected lung cancer by PCR based silver staining telomeric repeat amplification protocal (TRAP) respectively. Results The positive rate of telomerase was 100% in SCLC, but 84.8% in resected samples and 95.7% in biopsied samples in NSCLC. The positive rate of telomerase was 87.5%(35/40) in resected lung cancer tissues, 7.5%(3/40) in paracancerous tissues and 0%(0/40) in normal lung tissues (P<0.01). 82.5% (34/40) biopsied specimens of suspected lung cancer were detected with telomerase activity. Its sensitivity, specificity, and accurate rate was 96.4%, 71.4%, and 91.4% respectively for detection of lung cancer, Youden’s Index (J)=0.678,and SE(J)=0.174. Conclusion Telomerase may be a sensitive tumor marker of lung cancer. Detecting telomerase activity in preoperative fibro-optic bronchoscope biopsied specimens may contribute to early diagnosis of lung cancer.
Keywords:Lung neoplasms Telomerase Early diagnosis  
本文献已被 CNKI 万方数据 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号